|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
A TauRx Therapeutics drug designed to dissolve tangles of a protein called tau in the brain failed to slow cognitive and functional declines of Alzheimer's patients compared with a control.
Retrophin (RTRX), the biotech company that used to be run by indicted hedge fund manager Martin Shkreki, provides an interesting investment opportunity.
One biotech portfolio manager thinks Retrophin, the biotech company once run by indicted hedge fund manager Martin Shkreli, could be a promising investment.
Investors in Elan Corp plc saw new options begin trading today, for the January 2014 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ELN options chain for the new January 2014 contracts and identified the following put contract of particular interest.
The shareholders of Elan Corporation, plc (NYSE:ELN) ("Elan") today overwhelmingly approved the acquisition of Elan by Perrigo Company (“Perrigo”) (NYSE, TASE: PRGO) at two special meetings of Elan ...
The situation in Ireland is improving. Here's a way you can invest in that.
Andreas Halvorsen’s Viking Global teamed up with other tiger cubs in buyingaBaidu Inc (NASDAQ:BIDU). Viking initiated a new position in the Chinese language search engine with 2.67 million shar...
Elan Corporation, plc (NYSE:ELN) today reported its third quarter and first nine months 2013 financial results.
Elan Corporation, plc (NYSE:ELN) announced today that it will host a conference call on Thursday, October 24, 2013 at 8:30 a.
Elan Corporation, plc (NYSE:ELN) today announced that it has scheduled shareholder meetings for Monday, November 18, 2013 in connection with Perrigo Company’s (NYSE, TASE: PRGO) (“Perrigo”) proposed...
Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome.
Cramer remains bullish on Cree and thinks Harley-Davidson will continue riding to profit,
Gregg Greenberg writes that Zynga loses, fertiilzers stink, Ackman's big mouth proves awkward and more.
: 2013's M&A scene is clearly down, and PE's famed club deals are out.
The trading panel pondered the market's direction in a week of earnings and economic data.
Mergers are great news for every investor, Cramer said.
Stocks are falling Monday as investors retreat to the sidelines to await data on U.S. growth and an indication which way the Fed is leaning.
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Elan Corporation, plc (“Elan”) (NYSE:...
From humble roots in western Michigan, Perrigo is moving to Ireland so it can pay less in U.S. taxes.
Elan said it had agreed on an $8.6 billion takeover by pharmaceuticals company Perrigo.
U.S. stock futures are pointing to a sluggish open Monday ahead of the Fed's policy announcement on Wednesday.
A big ad merger between Omnicom and Publicis, plus a drug merger between Perrigo and Elan doesn't help lift stocks ahead of the Fed.
U.S. stock futures are lower; ad giants Omnicom and Publicis agree to a merger; Perrigo to buy Elan for $8.6 billion; Hertz to report earnings.
U.S. drugmaker Perrigo agrees to buy Ireland's Elan for $8.6 billion.
Elan Corporation, plc (NYSE:ELN) today reported its second quarter and first half 2013 financial results.
The SEC has charged Steven A. Cohen of SAC Capital with failing to supervise its portfolio managers.
Elan Corporation, plc (NYSE:ELN) announced today that the US Food and Drug Administration (FDA) has granted Fast Track Designation to its development program for ELND005 which was submitted for the treatment of ...
Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, July 24, 2013 at 8:30 a.
Men's Wearhouse can't like the way they look; Elan runs a circuitous path of Irish deal making; bombast crashes the Paris Air Show and more.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.